biotech

The Bayh-Dole Act: Boon or Bane?

Filed in archive Patents and Intellectual Property Rights on September 15, 2005

BlogPicture


Fortune75 runs a lengthy article on the Bayh-Dole Act or Patent and Trademark Ammendments Act, which promoted the participation of universities and federally funded institution in the commercialization of their patentable discoveries and inventions.

An excerpt:
"On the face of it, Bayh-Dole makes sense. Indeed, supporters say the law helped create the $43-billion-a-year biotech industry and has brought valuable drugs to market that otherwise would never have seen the light of day. What's more, say many scholars, the law has created megaclusters of entrepreneurial companies---each an engine for high-paying, high-skilled jobs---all across the land.

That all sounds wonderful. Except that Bayh-Dole's impact wasn't so much in the industry it helped create, but rather in its unintended consequence---a legal frenzy that's diverting scientists from doing science."


Read the full story here.

Permalink: The Bayh-Dole Act: Boon or Bane?

Tags: patent  IPR  biotech  dole  bayh  bayh+dole  boon+bane  dole+boon 

Vote for The Bayh-Dole Act: Boon or Bane?:

  • Currently 9.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.33 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells